Neumora Therapeutics Inc (NASDAQ: NMRA) is -83.87% lower on its value in year-to-date trading and has touched a low of $1.60 and a high of $21.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NMRA stock was last observed hovering at around $1.66 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $1.71, the stock is -8.29% and -65.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.45 million and changing 3.01% at the moment leaves the stock -82.48% off its SMA200. NMRA registered -91.35% loss for a year compared to 6-month loss of -85.57%.
The stock witnessed a -16.99% gain in the last 1 month and extending the period to 3 months gives it a -84.23%, and is 0.59% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.16% over the week and 6.98% over the month.
Neumora Therapeutics Inc (NMRA) has around 124 employees, a market worth around $276.27M and $0.00M in sales. Distance from 52-week low is 6.88% and -91.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-91.57%).
The EPS is expected to grow by 56.61% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 160.48M, and float is at 54.24M with Short Float at 18.91%.
Neumora Therapeutics Inc (NMRA) Insider Activity
The most recent transaction is an insider sale by BERNS PAUL L,. SEC filings show that BERNS PAUL L sold 13,871 shares of the company’s common stock on Feb 18 ’25 at a price of $1.69 per share for a total of $23468.0. Following the sale, the insider now owns 7.41 million shares.
Neumora Therapeutics Inc disclosed in a document filed with the SEC on Feb 18 ’25 that Milligan Michael Lee sold a total of 1,978 shares of the company’s common stock. The trade occurred on Feb 18 ’25 and was made at $1.69 per share for $3351.0. Following the transaction, the insider now directly holds 22470.0 shares of the NMRA stock.
Still, SEC filings show that on Feb 18 ’25, Aurora Daljit Singh (Chief Strategy Officer) disposed off 8,565 shares at an average price of $1.68 for $14347.0. The insider now directly holds 88,935 shares of Neumora Therapeutics Inc (NMRA).
